CytomX Therapeutics, Inc. (CTMX) KPIs and segments

CTMXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30

$2.04+0.00 (0.00%)

Close on Nov 13, 2026Market cap $444.52MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive CytomX Therapeutics's business

Coming soon

This tab will track the numbers specific to CytomX Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?